Commonwealth Equity Services, LLC Horizon Therapeutics Public LTD CO Transaction History

Commonwealth Equity Services, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$98.98 - $115.74 $66,811 - $78,124	-675 Reduced 2.63%	24,946 $2.89 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $432,373 - $504,361	-4,488 Reduced 14.91%	25,621 $2.64 Million
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $165,702 - $175,244	-1,544 Reduced 4.88%	30,109 $3.29 Million
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $2,433 - $4,438	-39 Reduced 0.12%	31,653 $3.6 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $267,261 - $384,063	-4,536 Reduced 12.52%	31,692 $1.96 Million

Q2 2022 Jul 19, 2022	BUY	$79.4 - $116.36 $56,771 - $83,197	715 Added 2.01%	36,228 $2.89 Million
Q1 2022 May 04, 2022	SELL	$86.42 - $109.81 $56,086 - $71,266	-649 Reduced 1.79%	35,513 $3.74 Million
Q4 2021 Jan 31, 2022	BUY	$98.56 - $119.91 $645,469 - $785,290	6,549 Added 22.12%	36,162 $3.9 Million
Q3 2021 Oct 29, 2021	BUY	$91.91 - $110.37 $356,978 - $428,677	3,884 Added 15.1%	29,613 $3.24 Million
Q2 2021 Aug 11, 2021	BUY	$86.24 - $95.92 $313,999 - $349,244	3,641 Added 16.48%	25,729 $2.41 Million
Q1 2021 May 04, 2021	BUY	$71.83 - $95.48 $663,781 - $882,330	9,241 Added 71.93%	22,088 $2.03 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $298,083 - $375,451	4,449 Added 52.98%	12,847 $939,000
Q3 2020 Nov 05, 2020	BUY	$55.23 - $79.93 $7,566 - $10,950	137 Added 1.66%	8,398 $652,000
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $5,617 - $10,598	-186 Reduced 2.2%	8,261 $459,000
Q1 2020 May 11, 2020	BUY	$24.87 - $38.56 $210,076 - $325,716	8,447 New	8,447 $250,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.